Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0. It has been cited 77 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: 5UG3DA047717
NIH
Grant: U01AG066623
NIH HHS
Grant: 5UG3DA047717 U01AG066623
NIDA NIH HHS
Grant: UG3 DA047717
National Institutes of Health
Grant: 5UG3DA047717-02
MOR/DOR Heterodimer Antagonists: A Novel Treatment for Opioid Dependence
National Institutes of Health
Grant: 3U01AG066623-01S1
IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia
FWCI
6.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals